Skip to product information
1 of 1

Alexa Fluor® 488 Rat Anti-Mouse CD39 Antibody (S-R641)

Alexa Fluor® 488 Rat Anti-Mouse CD39 Antibody (S-R641)

Catalog Number: S0B80587 Application: FCM Reactivity: Ms Conjugation: Alexa Fluor® 488 Brand: Starter
Price:
Regular price $85 USD
Regular price Sale price $85 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rat
Antigen CD39
Synonyms Ectonucleoside triphosphate diphosphohydrolase 1; NTPDase 1; ATP diphosphohydrolase (ATP-DPH; ATPDase); Ecto-ATP diphosphohydrolase 1 (Ecto-ATPDase 1; Ecto-ATPase 1); Ecto-apyrase; Lymphoid cell activation antigen; Nucleoside triphosphate diphosphohydrolase 1 (NTPDase1); Cd39; Entpd1
Location Membrane
Accession P55772
Clone Number S-R641
Antibody Type Rat mAb
Isotype IgG2a,k
Isotype Control S0B5537
Application FCM
Reactivity Ms
Positive Sample Fresh C57BL/6 mouse splenocytes
Purification Protein G
Concentration 0.5 mg/ml
Conjugation Alexa Fluor® 488
Physical Appearance Liquid
Storage Buffer

PBS, 1% BSA, 0.09% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 1μg per million cells in 100μl volume Ms

Background

CD39, also known as ectonucleoside triphosphate diphosphohydrolase-1 (ENTPD1), is a membrane-bound enzyme that hydrolyzes extracellular nucleotides such as ATP and ADP into AMP in a Ca²- and Mg²-dependent manner. It plays a crucial role in regulating immune responses and vascular function. In the tumor microenvironment, CD39 works with CD73 to convert ATP into adenosine, an immunosuppressive molecule that inhibits the activity of effector immune cells while promoting the function of regulatory immune cells, thus contributing to tumor immune evasion. This protein is highly expressed in various cell types within the tumor microenvironment, including tumor cells, stromal cells, endothelial cells, and immune cells. CD39 is also involved in thromboregulation and has been identified as a potential therapeutic target for cancer immunotherapy.

Picture

FC

Flow cytometric analysis of Mouse CD39 expression on fresh C57BL/6 mouse splenocytes. Fresh C57BL/6 mouse splenocytes were stained with Brilliant Violet 421™ Rat Anti-Mouse CD4 Antibody and either Alexa Fluor® 488 Rat IgG2a, k Isotype Control (left panel) or SDT Alexa Fluor® 488 Rat Anti-Mouse CD39 Antibody (right panel) at 2 μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.